Prostate Cancer - Results from #20520

High-risk prostate cancer: A disease of genomic instability - Abstract July 25, 2014

Current clinical presentation and treatment of localized prostate cancer in the United States - Abstract July 25, 2014

Primary gastrointestinal stromal tumor of the prostate: A case report and literature review - Abstract July 25, 2014

Diagnostic role of fluorodeoxyglucose positron emission tomography-computed tomography in prostate cancer - Abstract July 25, 2014

Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: A clinical decision analysis - Abstract July 25, 2014

Early biochemical relapse after radical prostatectomy: Which prostate cancer patient may benefit from a restaging 11C-choline PET/CT scan before salvage radiation therapy? - Abstract July 25, 2014

The metabolic syndrome is associated with more aggressive prostate cancer - Abstract July 25, 2014

Dose perturbation due to catheter materials in high-dose-rate interstitial 192Ir brachytherapy - Abstract July 25, 2014

New concepts concerning prostate cancer screening - Abstract July 25, 2014

Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer - Abstract July 25, 2014

Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time - Abstract July 25, 2014

A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed - Abstract July 25, 2014

Multiple repeat prostate biopsies and the detection of clinically insignificant cancer in men with large prostates - Abstract July 25, 2014

Patient opinions on prostate cancer screening are swayed by the United States Preventative Services Task Force recommendations - Abstract July 25, 2014

Drug costs in the management of metastatic castration-resistant prostate cancer in Canada - Abstract July 25, 2014

Elevated alkaline phosphatase velocity strongly predicts overall survival and the risk of bone metastases in castrate-resistant prostate cancer - Abstract July 25, 2014

Patient-reported outcome labeling claims and measurement approach for metastatic castration-resistant prostate cancer treatments in the United States and European Union - Abstract July 24, 2014

Prostatectomy pathology findings in an active surveillance population - Abstract July 24, 2014

Prostate cancer outcomes in France: Treatments, adverse effects and two-year mortality - Abstract July 24, 2014

Perceptions of active surveillance and treatment recommendations for low-risk prostate cancer: Results from a national survey of radiation oncologists and urologists - Abstract July 24, 2014

Page 1027 of 1458